Evidence map›Paper›PMID 39060643›Full record

ArticleBiochemical genetics2025

Impact of 5' Near Gene Variants of Mannose Binding Lectin (MBL2) on Breast Cancer Risk.

Shreya Singh Kashyap, Surmeet Kaur, Rajiv Kumar Devgan, Sumitoj Singh, Jatinder Singh, Manpreet Kaur

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shreya Singh KashyapDepartment of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.ORCID http://orcid.org/0000-0002-6808-1965
Surmeet KaurDepartment of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.ORCID http://orcid.org/0000-0001-5359-2749
Rajiv Kumar DevganDepartment of Radiotherapy and Oncology, Government Medical College, G.N.D. Hospital, Amritsar, Punjab, India.
Sumitoj SinghSurgery Unit II, Government Medical College, G.N.D. Hospital, Amritsar, Punjab, 143001, India.
Jatinder SinghDepartment of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
Manpreet KaurDepartment of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. dr.manpreetdhuna@gmail.com.ORCID http://orcid.org/0000-0003-0758-6078

Funding

Council of Scientific and Industrial Research, India 09/254(0295)/2019-EMR-I
6 · The paper itself

Abstract

The immune system plays a bifaceted role in tumour development through modulation of inflammation. MBL binds to damage-associated molecular patterns and induces inflammation through the activation of complement pathway. Dysregulated inflammation plays a major role in breast cancer pathogenesis, thereby suggesting its contribution towards breast cancer risk. Literature asserts single-nucleotide polymorphisms (SNPs) modulating serum MBL levels. Therefore, studying MBL2 SNPs in breast cancer might provide valuable insight in the disease pathogenesis. The present case-control association study aimed to elucidate the association between MBL2 5' near gene SNPs and breast cancer risk. Breast cancer patients were recruited from Government Medical College, G.N.D. Hospital, Amritsar. The age- and gender-matched genetically unrelated healthy individuals, from adjoining regions, with no history of malignancy up to three generations were recruited as controls. The SNPs of MBL2 from the 5' near gene region with putative functional significance were selected based upon the in silico analysis and literature review. The genotypic, allelic and haplotype frequencies for the studied variants were assessed and compared in the study participants by ARMS-PCR and PCR-RFLP. No difference in allelic, genotypic and haplotype frequencies was reported for rs7096206, rs7084554 and rs11003125 in both the participant groups. rs7084554 (CC) was found to confer risk towards hormone receptor-positive breast cancer. An intermediate LD was observed between rs7084554 and rs11003125. The study reports association between MBL2 variant (rs7084554) and hormone receptor-positive breast cancer risk. Further research in this direction might validate the findings.

Indexed as

Breast NeoplasmsGenetic Predisposition to DiseaseMannose-Binding LectinPolymorphism, Single NucleotideAdultCase-Control StudiesFemaleGene FrequencyHaplotypesHumansMiddle AgedMannose-Binding LectinMBL2 protein, humanGenotypingHormone receptor-positive breast cancerInfiltrating ductal carcinomars7084554Single nucleotide polymorphism

Identifiers

PMID39060643

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.